• Explore /
  • Poster
  • / NRG Oncology/RTOG 9601, a phase III trial in prostate cancer patients: Anti-androgen therapy (AAT) with bicalutamide during and after salvage radiation therapy (RT) following radical prostatectomy (RP) and an elevated PSA.

NRG Oncology/RTOG 9601, a phase III trial in prostate cancer patients: Anti-androgen therapy (AAT) with bicalutamide during and after salvage radiation therapy (RT) following radical prostatectomy (RP) and an elevated PSA.

Abstract Poster

Authors

null

William U. Shipley

Massachusetts General Hospital, Harvard Medical School, Boston, MA

William U. Shipley , Stephanie L. Pugh , Himu R. Lukka , Pierre Major , Niall M. Heney , David A. Grignon , Oliver Sartor , Malti Patel , Jean-Paul Bahary , Anthony L. Zietman , Thomas Michael Pisansky , Kenneth Lee Zeitzer , Colleen Anne Lawton , Felix Yi-Chung Feng , Richard Dana Lovett , Alexander G. Balogh , Luis Souhami , Seth A. Rosenthal , Kevin Kerlin , Howard M. Sandler

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2016 Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session A: Prostate Cancer

Track

Prostate Cancer,Prostate Cancer

Sub Track

Prostate Cancer - Localized Disease

Clinical Trial Registration Number

NCT00002874

Citation

J Clin Oncol 34, 2016 (suppl 2S; abstr 3)

DOI

10.1200/jco.2016.34.2_suppl.3

Abstract #

3

Poster Bd #

A3

Abstract Disclosures

Similar Posters

First Author: Himu Lukka

First Author: Ronald C. Chen

First Author: Alicia K. Morgans

First Author: Alan Dal Pra